NERVOUS SYSTEM TOXICOLOGY
OUTLINE
|
|
|
|
Nervous system development |
|
Nervous system anatomy and physiology |
|
Manifestations of neurotoxicity |
|
Neuronopathies |
|
Axonopathies |
|
Myelinopathies |
|
Neurotransmission-associated
anomalities |
|
Prototypical toxicological agents |
|
Methylmercury |
|
Carbon disulfide |
|
Lead |
|
Nicotine |
|
Organochlorine insectides |
|
Organophosphorous insectides |
|
Venoms |
NERVOUS SYSTEM
NERVOUS SYSTEM
BRAIN
NERVOUS SYSTEM
SPINAL CORD
NERVOUS SYSTEM
NERVOUS SYSTEM ANATOMY
NERVOUS SYSTEM ANATOMY
NERVOUS SYSTEM ANATOMY
NERVOUS SYSTEM ANATOMY
Slide 11
MANIFESTATIONS OF
NEUROTOXICITY
|
|
|
Neuronopathies |
|
Axonopathies |
|
Myelinopathies |
|
Neurotransmission-associated
anomalities |
MANIFESTATIONS OF
NEUROTOXICITY
|
|
|
Injury or death to neurons |
|
Irreversible loss |
|
Initial injury followed by apoptosis or
necrosis |
|
Caused by CO, ethanol, carbon
tetrachloride, methyl mercury, lead |
MANIFESTATIONS OF
NEUROTOXICITY
|
|
|
Primary site of toxicity is axon |
|
Degeneration of axon, surrounding
myelin, but cell body remains intact |
|
Irreversible in CNS, but reversible in
PNS |
|
Caused by CS2, acrylamide,
gold, organophosphorous esters |
MANIFESTATIONS OF
NEUROTOXICITY
MANIFESTATIONS OF
NEUROTOXICITY
|
|
|
Intramyelinic edema |
|
Demyelination |
|
Remyelination in CNS occurs to a
limited extent |
|
Remyelination in PNS done by Schwann
cells |
|
Caused by amiodarone, disulfiram,Pb |
MANIFESTATIONS OF
NEUROTOXICITY
|
|
|
Interruption of impulse transmission |
|
Blockade of transsynaptic communication |
|
Inhibition of neurotransmitter uptake |
|
Interference with second-messenger
systems |
|
Caused by nicotine, amphetamines,
cocaine |
MANIFESTATIONS OF
NEUROTOXICITY
Slide 19
MERCURY
|
|
|
|
Vapor from degassing in earth’s crust |
|
Methylated by microorganisms to CH3Hg |
|
CH3Hg is most significant
form of Hg in terms of toxicity from environmental exposure |
|
Bioconcentration in aquatic food chain |
|
90 to 95% absorption in GIT |
|
Crosses placenta |
MERCURY
|
|
|
|
Neurotoxic effects lead to, |
|
Paresthesia |
|
Ataxia |
|
Neurasthenia |
|
Vision and hearing loss |
|
Coma and death |
|
Neurotoxic effects due to focal
necrosis of neurons |
MERCURY
|
|
|
The critical or lowest level of
observed adverse health effect in adults is paresthesia |
|
The average long-term intake associated
with paresthesia calculated to be 300 μg/day for an adult |
|
Poisoning therapy utilizes chelators
such as cysteine, penicillamine, thiol resins |
CARBON DISULFIDE
|
|
|
Used in the production of viscose
rayon, cellophane, pesticides, as a solubilizer for waxes and oils |
|
Exposure is predominantly occupational |
|
OSHA has established a PEL of 20 ppm as
an 8-h TWA |
CARBON DISULFIDE
|
|
|
Direct interaction with free amine and
sulfhydryl groups |
|
Microsomal activation to reactive
sulfur intermediates that bind macromolecules |
|
Produce neuronal degeneration in CNS;
in PNS produce myelin swelling and fragmentation |
LEAD
|
|
|
Ubiquitous toxic metal |
|
Primary route of exposure is by
ingestion |
|
Source is from lead-based paint,
contaminated drinking water, lead-glazed pottery |
|
Encephalopathy occurs at blood lead
levels of 80-100 μg/dL |
LEAD
|
|
|
|
Symptoms of encephalopathy include
lethargy, vomiting, irritability, loss of appetite, and dizziness |
|
Progression of symptoms lead to ataxia,
reduced level of consciousness, which may progress to coma and death |
|
Recovery is often associated with
life-long epilepsy, mental retardation, optic neuropathy, blindness |
LEAD
|
|
|
|
Chronic toxicity affects PNS; Schwann
cell degeneration |
|
Mechanisms of toxicity include, |
|
Impairment of cell-cell connections |
|
Alterations in neurotransmitter levels |
|
Disrupts calcium metabolism |
NICOTINE
|
|
|
|
Exposure from smoking |
|
Binds to nicotinic cholinergic
receptors |
|
Increase in HR |
|
Elevated BP |
|
Acute overdose leads to excessive
stimulation of nicotinic receptors leading to ganglionic paralysis |
ORGANOCHLORINE INSECTICIDES
|
|
|
DDT, lindane, dieldrin |
|
High lipid solubility, low degradation
rate |
|
Persistence in environment,
bioconcentration and biomagnification in food chains |
|
Produce disturbances in ion transport
across axon leading to increased excitability and seizures |
ORGANOPHOSPHOROUS
PESTICIDES
|
|
|
Malathion, parathion, “nerve gases” |
|
Inhibits acetylcholinesterase (AChE)
leading to continuous stimulation |
|
Neurobehavioral, cognitive,
neuromuscular disturbances |
|
Intermediate syndrome |
|
Death from respiratory distress |
VENOMS
|
|
|
|
Scorpions, spiders |
|
Contain low molecular weight proteins
that affect ion transport along axon |
|
Impairs action potential |
|
Symptoms include tachycardia,
respiratory distress |